SBC Medical Group Holdings Inc (SBC) company profile
Close on Nov 13, 2026Market cap $755.93MP/E 15.6Yield –
About SBC Medical
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
SBC Medical Group Holdings Incorporated operates as a healthcare services and clinic management holding company. Through its operating subsidiaries, the company provides support services to healthcare providers, which include medical corporations, franchisee clinics, and independent physicians. Its core business activities encompass management services, clinic franchising, procurement services, and equipment or facility rental services. The company primarily serves healthcare partners, medical corporations, and affiliated clinics that offer medical treatments, aesthetic healthcare, cosmetic surgery, and osteopathic care.
The company maintains business operations and clinic affiliations internationally, with activities and subsidiaries located across Japan, Singapore, Vietnam, and the United States. Its network includes medical corporations and independently operated clinics across these jurisdictions. SBC Medical Group Holdings Incorporated maintains its principal executive offices and corporate headquarters in Irvine, California.
Summary of the business section of SBC Medical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- SBC Medical Group Holdings Inc
- Founded
- 2022
- Headquarters
- Irvine, CA
- Address
- 200 Spectrum Center Dr., Suite 300 92618
- Phone
- (949) 593-0250
- Website
- sbc-holdings.com
- Employees
- 863, Dec 31, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- MaloneBailey, LLP, Tokyo, Japan
Stock & identifiers
- Ticker
- SBC
- Other tickers
- SBCWW
- Former tickers
- PTWO until Sep 20, 2024
- Exchange
- Nasdaq
- IPO date
- Aug 8, 2022
- Shares outstanding
- 103M, Jul 31, 2026
- Public float
- $48.20M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1930313
- CUSIP
- 73245B107
- ISIN
- US73245B1070
- FIGI
- BBG019TC4SS5
- Share class FIGI
- BBG019TC4TM9
- EIN
- 88-1263511
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Yoshiyuki Aikawa | Chairman and CEO, Director | 83,839,460 |
| Miki Yamazaki | Chief Strategy Officer | – |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Total | vs. prior year |
|---|---|---|---|---|
| Yoshiyuki Aikawa Chief Executive Officer (principal executive officer) | $12.00M | – | $12.00M | -17% |
| Yuya Yoshida Chief Financial Officer and Chief Operating Officer | $316.73K | $99.34K | $416.07K | +37% |
| Miki (Shimizu) Yamazaki Chief Strategy Officer | $275.78K | $83.39K | $359.17K | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Aug 8, 2022
- Offer price
- $10.00
- Securities offered
- 10,000,000
- Gross proceeds
- $100.00M
- Exchange
- Nasdaq
- First trading day
- Sep 26, 2022
- First-day close
- $9.96-0.4%
- Lock-up ends (est.)
- Mar 25, 2023
“Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one redeemable warrant.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 863 regular employees globally (excluding employees of the managed clinics/medical corporations we support), a majority of which are located in Japan, Singapore, Vietnam, and the United States.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 14, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Sep 20, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Sep 20, 2024 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 18, 2024 | Delisting | Notice of delisting from exchange (Form 25) |
| Aug 29, 2024 | Name change | Name changed from Pono Capital Two, Inc. to SBC Medical Group Holdings Inc |
| Aug 14, 2024 | Late filing | Notification of late filing |
| Aug 12, 2024 | Merger vote | Definitive merger proxy statement |
| May 15, 2024 | Late filing | Notification of late filing |
| May 8, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 4, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Aug 8, 2022 | IPO | Initial public offering priced (424B4 prospectus) |
| Aug 2, 2022 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?